by Clinical Neuropsychologist Online | Wednesday, January 22, 2025 | Dementia
Abstract INTRODUCTION We investigated the efficacy of a multidomain intervention (MI) via face-to-face and video communication platforms using a tablet personal computer application in patients with mild cognitive impairment (MCI). METHODS Three hundred participants...
by Clinical Neuropsychologist Online | Friday, January 17, 2025 | Dementia
Abstract INTRODUCTION Greater white matter hyperintensities (WMHs) on magnetic resonance imaging (MRI) are seen with transactive response DNA-binding protein 43 (TDP-43) pathology in frontotemporal lobar degeneration (FTLD-TDP). WMH associations with TDP-43 pathology...
by Clinical Neuropsychologist Online | Friday, January 17, 2025 | Dementia
Abstract INTRODUCTION Medicare’s Annual Wellness Visit (AWV) is a logical opportunity for early detection of cognitive impairment, but recent data for uptake and cognitive assessments during it are lacking. METHODS We surveyed Medicare beneficiaries of a...
by Clinical Neuropsychologist Online | Friday, January 17, 2025 | Dementia
Abstract INTRODUCTION Alzheimer’s disease (AD) is the most common neurodegenerative disease, characterized by damage to cortical circuits. However, the mechanisms underlying AD-associated changes in long-range circuits remain poorly understood. METHODS In this...
by Clinical Neuropsychologist Online | Friday, January 17, 2025 | Dementia
Abstract INTRODUCTION Novel fluid biomarkers for tracking neurodegeneration specific to Alzheimer’s disease (AD) are greatly needed. METHODS Using two independent well-characterized cohorts (n = 881 in total), we investigated the group differences in plasma...
